Viridian Therapeutics, Inc. — Form D
Viridian Therapeutics, Inc. of WALTHAM, MA, a company, filed a Form D exempt-offering notice with the SEC on 2020-05-08. The offering totals $5.0M, of which $2.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-05-08
- Form: D
- Accession: 0001811466-20-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $2.0M
- Remaining: $3.0M
- Investors: 2
- Date of first sale: 2020-04-24
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-366547
Issuer
- Name: Viridian Therapeutics, Inc.
- CIK: 0001811466
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 203 CRESCENT STREET, WALTHAM, MA, 02453
- Phone: 919-949-8552
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Tomas Kiselak | Director | West Conshohocken, PA |
| Peter Harwin | Director | West Conshohocken, PA |
| Jonathan Violin | Director | Waltham, MA |
| Jonathan Violin | Executive Officer | Waltham, MA |
Other filings by this issuer (1)
More